scholarly journals A Prediction Model Based on Biomarkers and Clinical Characteristics for Detection of Lung Cancer in Pulmonary Nodules

2017 ◽  
Vol 10 (1) ◽  
pp. 40-45 ◽  
Author(s):  
Jie Ma ◽  
Maria A. Guarnera ◽  
Wenxian Zhou ◽  
HongBin Fang ◽  
Feng Jiang
Keyword(s):  
Lung Cancer ◽  
Prediction Model ◽  
Clinical Characteristics ◽  
Pulmonary Nodules ◽  
Model Based

scholarly journals A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Wenqun Xing ◽  
Haibo Sun ◽  
Chi Yan ◽  
Chengzhi Zhao ◽  
Dongqing Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Dna Methylation ◽  
Prediction Model ◽  
Mayo Clinic ◽  
Prediction Models ◽  
Characteristic Curve ◽  
Pulmonary Nodules ◽  
Receiver Operator Characteristic Curve ◽  
Support Vector ◽  
Model Based

Abstract Background Lung cancer remains the leading cause of cancer deaths across the world. Early detection of lung cancer by low-dose computed tomography (LDCT) can reduce the mortality rate. However, making a definitive preoperative diagnosis of malignant pulmonary nodules (PNs) found by LDCT is a clinical challenge. This study aimed to develop a prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant pulmonary nodules from benign PNs. Methods We assessed three DNA methylation biomarkers (PTGER4, RASSF1A, and SHOX2) and clinically-relevant variables in a training cohort of 110 individuals with PNs. Four machine-learning-based prediction models were established and compared, including the K-nearest neighbors (KNN), random forest (RF), support vector machine (SVM), and logistic regression (LR) algorithms. Variables of the best-performing algorithm (LR) were selected through stepwise use of Akaike’s information criterion (AIC). The constructed prediction model was compared with the methylation biomarkers and the Mayo Clinic model using the non-parametric approach of DeLong et al. with the area under a receiver operator characteristic curve (AUC) analysis. Results A prediction model was finally constructed based on three DNA methylation biomarkers and one radiological characteristic for identifying malignant from benign PNs. The developed prediction model achieved an AUC value of 0.951 in malignant PNs diagnosis, significantly higher than the three DNA methylation biomarkers (0.912, 95% CI:0.843–0.958, p = 0.013) or Mayo Clinic model (0.823, 95% CI:0.739–0.890, p = 0.001). Validation of the prediction model in the testing cohort of 100 subjects with PNs confirmed the diagnostic value. Conclusion We have shown that integrating DNA methylation biomarkers and radiological characteristics could more accurately identify lung cancer in subjects with CT-found PNs. The prediction model developed in our study may provide clinical utility in combination with LDCT to improve the over-all diagnosis of lung cancer.

scholarly journals A Prediction Model Based on DNA Methylation Biomarkers and Radiological Characteristics for Identifying Malignant From Benign Pulmonary Nodules

2020 ◽  
Author(s):  
Wenqun Xing ◽  
Haibo Sun ◽  
Chi Yan ◽  
Chengzhi Zhao ◽  
Dongqing Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Dna Methylation ◽  
Prediction Model ◽  
Characteristic Curve ◽  
Multivariate Logistic Regression Analysis ◽  
Pulmonary Nodules ◽  
Diagnostic Value ◽  
Receiver Operator Characteristic Curve ◽  
Model Based ◽  
Diagnosis Of Lung Cancer

Abstract BackgroundLung cancer remains the leading cause of cancer deaths across the world. Early detection of lung cancer by low-dose computed tomography (LDCT) can reduce the mortality rate. However, making a definitive preoperative diagnosis of malignant pulmonary nodules (PNs) found by LDCT is a clinical challenge. This study aimed to develop a prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant pulmonary nodules from benign PNs. MethodsWe assessed three DNA methylation biomarkers (PTGER4, RASSF1A, and SHOX2) in a training cohort of 110 individuals with PNs. Using univariate and multivariate logistic regression analysis, we developed a prediction model based on the three DNA methylation biomarkers and one radiological characteristic for identifying malignant from benign PNs. The performance of the prediction model with that of the methylation biomarkers and the Mayo Clinic model were compared using the non-parametric approach of DeLong et al. with the area under a receiver operator characteristic curve (AUC) analysis. ResultsThe developed prediction model achieved a sensitivity of 87.3% and a specificity of 95.7% with an AUC value of 0.951 in malignant PNs diagnosis, being significantly higher than the three DNA methylation biomarkers (84.1% sensitivity and 89.4% specificity, p=0.013) or clinical/radiological characteristics (76.2% sensitivity and 87.2% specificity, p=0.001) alone. Validation of the prediction model in the testing cohort of 100 subjects with PNs confirmed the diagnostic value.ConclusionWe have shown that integrating DNA methylation biomarkers and radiological characteristics could more accurately identify lung cancer in subjects with CT-found PNs. The prediction model developed in our study may provide clinical utility in combination with LDCT to improve the over-all diagnosis of lung cancer.

scholarly journals Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model

2016 ◽  
Vol 89 (1060) ◽  
pp. 20160016 ◽  
Author(s):  
Henry Zhao ◽  
Henry M Marshall ◽  
Ian A Yang ◽  
Rayleen V Bowman ◽  
John Ayres ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Prediction Model ◽  
Risk Prediction ◽  
Lung Cancer Risk ◽  
Pulmonary Nodules ◽  
Risk Prediction Model ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document